ClinicalTrialsFinder

Indolent Non-hodgkin Lymphoma Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1

Studying TAK-243 in Patients With Advanced Cancer

Metastatic Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+3 more
National Cancer Institute (NCI)95 enrolled1 locationNCT06223542